NO20023107D0 - Carboxamide-diazepine derivatives, method of preparation, use as medicines, pharmaceutical preparations and uses thereof - Google Patents

Carboxamide-diazepine derivatives, method of preparation, use as medicines, pharmaceutical preparations and uses thereof

Info

Publication number
NO20023107D0
NO20023107D0 NO20023107A NO20023107A NO20023107D0 NO 20023107 D0 NO20023107 D0 NO 20023107D0 NO 20023107 A NO20023107 A NO 20023107A NO 20023107 A NO20023107 A NO 20023107A NO 20023107 D0 NO20023107 D0 NO 20023107D0
Authority
NO
Norway
Prior art keywords
medicines
carboxamide
preparation
pharmaceutical preparations
products
Prior art date
Application number
NO20023107A
Other languages
Norwegian (no)
Other versions
NO20023107L (en
Inventor
Neerja Bhatnagar
Jacques Mauger
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023107(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20023107D0 publication Critical patent/NO20023107D0/en
Publication of NO20023107L publication Critical patent/NO20023107L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention concerns products of formula (I) wherein: R1 represents in particular -C(O) -R5, -SO2 -R5 or -C(O) -NR6R5, R2 and R7 are such that either R7 represents a hydrogen atom and R2 is such that the group (a) represents the radical of a natural or non-natural amino acid, or R2 and R7 form together a cycle with the nitrogen and carbon atom whereto they are bound, R3 represents in particular the radical -CH=N2 or -CH2-L-R4, R4 represents in particular a linear or branched alkyl radical, and their additive salts with mineral or organic acids or with mineral or organic bases of said products of formula (I). The invention also concerns the method for preparing said products and their use as medicines.
NO20023107A 1999-12-28 2002-06-27 Carboxamide-diazepine derivatives, method of preparation, use as medicines, pharmaceutical preparations and uses thereof NO20023107L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9916567A FR2802927B1 (en) 1999-12-28 1999-12-28 NOVEL DIAZEPINE CARBOXAMIDE DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND THEIR NEW USE
PCT/FR2000/003622 WO2001047930A1 (en) 1999-12-28 2000-12-21 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof

Publications (2)

Publication Number Publication Date
NO20023107D0 true NO20023107D0 (en) 2002-06-27
NO20023107L NO20023107L (en) 2002-08-27

Family

ID=9553901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023107A NO20023107L (en) 1999-12-28 2002-06-27 Carboxamide-diazepine derivatives, method of preparation, use as medicines, pharmaceutical preparations and uses thereof

Country Status (26)

Country Link
EP (1) EP1246824B1 (en)
JP (1) JP2003519152A (en)
KR (1) KR20020062772A (en)
AT (1) ATE268775T1 (en)
AU (1) AU780522B2 (en)
BR (1) BR0016845A (en)
CA (1) CA2395275A1 (en)
DE (1) DE60011473T2 (en)
DK (1) DK1246824T3 (en)
EA (1) EA005288B1 (en)
EE (1) EE200200362A (en)
ES (1) ES2218275T3 (en)
FR (1) FR2802927B1 (en)
HR (1) HRP20020558A2 (en)
HU (1) HUP0203921A3 (en)
IL (1) IL150419A0 (en)
MX (1) MXPA02006413A (en)
NO (1) NO20023107L (en)
NZ (1) NZ519884A (en)
PL (1) PL355950A1 (en)
PT (1) PT1246824E (en)
SI (1) SI1246824T1 (en)
SK (1) SK9092002A3 (en)
WO (1) WO2001047930A1 (en)
YU (1) YU47502A (en)
ZA (1) ZA200205221B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220115062A (en) 2021-02-09 2022-08-17 (주)오스티오뉴로젠 Pharmaceutical Composition For Treating and Preventing Osteoporosis Comprising Compounds of Chromone Scaffold

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
HUP0203921A3 (en) 2005-01-28
KR20020062772A (en) 2002-07-29
DK1246824T3 (en) 2004-10-18
HUP0203921A2 (en) 2003-03-28
PL355950A1 (en) 2004-05-31
FR2802927A1 (en) 2001-06-29
NO20023107L (en) 2002-08-27
AU2688801A (en) 2001-07-09
ES2218275T3 (en) 2004-11-16
SK9092002A3 (en) 2003-04-01
ZA200205221B (en) 2003-09-04
JP2003519152A (en) 2003-06-17
IL150419A0 (en) 2002-12-01
DE60011473T2 (en) 2005-06-30
BR0016845A (en) 2002-10-15
CA2395275A1 (en) 2001-07-05
FR2802927B1 (en) 2002-03-01
SI1246824T1 (en) 2004-10-31
ATE268775T1 (en) 2004-06-15
AU780522B2 (en) 2005-03-24
DE60011473D1 (en) 2004-07-15
EA005288B1 (en) 2004-12-30
NZ519884A (en) 2005-03-24
EP1246824A1 (en) 2002-10-09
PT1246824E (en) 2004-10-29
EP1246824B1 (en) 2004-06-09
MXPA02006413A (en) 2002-11-29
YU47502A (en) 2005-03-15
WO2001047930A1 (en) 2001-07-05
EE200200362A (en) 2003-08-15
HRP20020558A2 (en) 2004-02-29
EA200200721A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
ES2186253T3 (en) A METHOD FOR CONTROLLING THE RHEOLOGY OF A WATERY FLUID AND GELIFYING AGENT FOR SUCH CONTROL.
NO971889D0 (en) Compounds and compositions for delivery of active agents
ATE90107T1 (en) PEPTIDES WITH COLLAGENASE INHIBITING ACTIVITIES.
RS49906B (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
NO924929L (en) PHARMASOEYTIC ACTIVE BENZOQUINAZOLINE COMPOUNDS
NO932120L (en) Biphenyl derivatives, drugs containing them, and methods for their preparation
MXPA03000547A (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder.
CR7249A (en) DERIVATIVES OF DIAMINE, PROCESS TO PRODUCE THE DERIVATIVES OF DIAMINE, AND FUNGUICIDES CONTAINING THE DERIVATIVES OF DIAMINE AS ACTIVE INGREDIENT
ATE295716T1 (en) MEANS AND METHOD FOR PERMANENT HAIR SHAPING BASED ON 2-MERCAPTOPROPIONIC ACID AMIDES AND METHOD FOR THE PRODUCTION THEREOF
NO20023107D0 (en) Carboxamide-diazepine derivatives, method of preparation, use as medicines, pharmaceutical preparations and uses thereof
MXPA01013148A (en) Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use.
GB1415471A (en) Phenylethylamine derivatives
YU81502A (en) Cyclopostins, a method for their production and the use of the same
ATE244258T1 (en) HALO DERIVATIVES OF 9-DEOXO-9A-AZA-9A-HOMERYTHROMYCIN A
HUP0100564A2 (en) Matrix metalloproteinase inhibitors and pharmaceuticals comprising them
CA2296984A1 (en) Composition for topical application to the skin and/or skin appendages, comprising at least one compound containing a phenyloxime fragment
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
CO4950516A1 (en) NEW BENCILAMINE DERIVATIVES AND PHENYLTILAMINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND USE AS MEDICINES
HUP0002727A2 (en) Methods for reducing fibrinogen using benzotiophene derivatives
CY1107483T1 (en) Pyridazine derivatives, their use as pharmaceutical preparations, and their preparation process
NO974598D0 (en) Phenoxyethylamine derivatives with high affinity for the 5-HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
FI970452A (en) Inhibition of leukotriene biosynthesis by urea derivatives
ES2060226T3 (en) PROCEDURE FOR OBTAINING N ', N-BIS (3-AMINOPHENYL) -UREAS.
DE69920748D1 (en) PSEUDOPEPTIDES WITH INHIBITING EFFECT ON PROTEIN TYROSINKINASES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK1240162T3 (en) 3-Imino-1,2-dithiol derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application